Clinithink

company

About

Clinithink offers cloud-based text processing capability to support data analytics, coding, and decision support in healthcare applications.

  • 11 - 50

Details

Last Funding Type
Series B
Industries
Analytics,Artificial Intelligence,Clinical Trials,Health Care,Information Services,Information Technology,Life Science,Software
Founded date
Jan 1, 2009
Number Of Employee
11 - 50
Operating Status
Active

Clinithink, a London, UK-based healthcare software company. Led by CEO Chris Tackaberry, Clinithink has developed cloud-based text processing capability that can be used to support data analytics, coding and decision support in healthcare applications. Its patent-pending Clinical Language Indexing software (CLiX) uses Natural Language Processing (NLP) to construct coded output from physicians’ notes using industry data standards (ICD-9, ICD-10, and SNOMED CT).

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
Clinithink has raised a total of — in funding over 2 rounds. Their latest funding was raised on Mar 3, 2019 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 3, 2019 Series B 1 Merck Detail
Apr 20, 2012 Series A 1 Vanguard Atlantic Detail

Investors

Number of Lead Investors
Number of Investors
2
2
Clinithink is funded by 2 investors. Merck and Vanguard Atlantic are the most recent investors.
Investor Name Lead Investor Funding Round
Merck Yes Series B
Vanguard Atlantic Yes Series A